Verisity Announces SureCov 3.0
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aug. 27, 2001--Verisity,
Ltd. (Nasdaq:VRST), the leading provider of functional verification
automation software tools, today announced the immediate availability
of SureCov(TM) version 3.0. The latest release gives users a boost in
performance through several enhancements, including a unique new
feature called re-instrumentation that gives users more control over
their coverage. Additionally, SureCov 3.0 features new user
interfaces, easing users' ability to view, analyze and manage their
coverage data more effectively.
``SureCov has always been the performance leader and this latest
release further solidifies this position,'' said Michael Mertz,
director of product marketing for Verisity. ``We've also added some
unique features that put more control of the coverage process in the
hands of users. SureCov is the fastest, most versatile code coverage
solution available.''
The performance boost in SureCov 3.0 comes from several
enhancements: two new features and a restructured database. One of the
new features, called re-instrumentation, is completely unique to
SureCov and enables users to better manage the coverage process. With
re-instrumentation, users get a boost in performance proportionate to
the coverage already attained. For example, a user can instruct
SureCov to remove metrics for previously covered code, allowing
SureCov to cover and track metrics for only the uncovered portion of
the design. In this way, users direct the coverage to the problematic
design areas, reducing the overhead in each successive simulation,
resulting in a dramatic speedup in the users' verification.
``SureCov 3.0 is the code coverage tool of choice for our
verification methodology,'' said P.J. Sherhart, Member of the Technical
Staff at Agere Systems. ``We recommend it to others because it's
extremely easy to use, plugs easily into your design flow and helps
you quickly pinpoint areas in the design that require additional
verification effort.''
Other key capabilities contributing to the performance boost in
version 3.0 includes a restructured database and increased flexibility
in allowing users to select block-only or combined block and arc
coverage. The restructured database allows for better design
compaction thus allowing SureCov to support larger designs while
increasing performance. With the new block-only coverage option, users
can target coverage improvement at the block level only, without
incurring additional performance overhead through a combined block and
arc coverage.
SureCov 3.0 also includes new graphical user interface (GUI)
features including test ranking and database merging, support for
foreign or protected modules, and selective instrumentation control of
design directories and files. The new GUIs make it easier for users to
view, analyze and manage their coverage data. Support for foreign or
protected modules allow customers to incorporate modules written in
other languages in SureCov's verification environment. Selective
instrumentation control adds greater flexibility by allowing users to
selectively disable coverage for design libraries and files.
Pricing and Availability
SureCov v3.0 is available now on the Linux Operating System,
Solaris and HP workstations running HP-UX. The price is $15,000 U.S.
for a floating LAN license.
About Verisity
Verisity is the leading provider of proprietary technologies and
software products used to efficiently verify designs of electronic
systems and complex integrated circuits that are essential to the
communications and other high growth segments of the electronics
industry. Verisity's products automate the process of detecting flaws
in these designs, enabling customers to deliver higher quality
products, accelerate time-to-market and reduce overall product
development costs.
Verisity Design, Inc.'s principal executive offices are located in
Mountain View, CA. Verisity's principal research and development
offices and the corporate headquarters of Verisity Ltd. are located in
Rosh Ha'ain, Israel. For more information, see Verisity's web site at
www.verisity.com.
Note to Editors: Verisity is a registered trademark and SureCov is
a trademark of Verisity Design, Inc. All other trademarks are the
property of their respective holders.
Contact:
Verisity Design, Inc.
Jennifer Bilsey, 650/934-6823
jen@verisity.com
|